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Abstract
Objective: The association between parity and type 2 diabetes has been studied in developed countries and in
Singapore and Chinese women but not in Hispanics. Herein we evaluated the association between parity (number
of live births) with diabetes in a group of Hispanic postmenopausal women from Colombia.
Research design and methods: Herein we evaluated the association between parity and diabetes in a population
of 1,795 women from Colombia. Women were divided in birth categories (0 [referent], 1 or 2, 3–5, 6 or > births).
Medical history of diabetes and anthropometric characteristics were recorded. Logistic regressions were performed
in order to find the association between parity and diabetes in bivariable and multivariable models after controlling
for age, body mass index (BMI), waist hip ratio (WHR) and diabetes family history, among other variables.
Results: In our study, there was an association between parity and diabetes after adjusting for age, BMI and
diabetes family history in the multiparous women groups when compared to the women with no births (Referent
group) [1–2 births vs. referent OR 5.2 (95 CI 1.2–22.9), 3–5 births vs. referent OR 5.5 (1.3–23.0) and ≥6 births vs.
referent OR 7.5 (1.8–31.8), respectively]. The association was maintained in two of the groups in the multivariable
analysis [OR 5.0 (1.1–22.9) and 5.3 (1.2–23.5)], for 1 or 2 births and 6 or > births versus 0 births, respectively. Positive
diabetes family history and WHR were also associated with an increased risk of diabetes [OR 4.6 (3.0–7.0) and 4.1
(2.0–8.1), respectively].
Conclusions: In postmenopausal Hispanic women, multiparity, as well as a positive family history of diabetes and a
high waist-hip ratio were associated with higher diabetes risk.
Keywords: Type 2 diabetes, Parity, Hispanic women
Background
During each pregnancy there are known physiological
changes, including: insulin resistance, fat accumulation,
dyslipidemia, and inflammation [1-6] that could have an
impact on the risk of diabetes and other cardio-metabolic
disorders later in life.
In multiparous women, the aforementioned physio-
logical changes occurring during each gestation may
have lasting effects in the health of the mother which
could transcend beyond the gestational period and
increase the risk of metabolic syndrome, diabetes and
cardiovascular disease later in life [7-12].
Currently there is evidence suggesting an association
between childbearing and the risk of type 2 diabetes in
women in populations in both developed and developing
countries [9-12] however in some cases this association
has been lost after controlling for confounding variables
such as age and obesity [13]. To our knowledge there
are currently no studies evaluating this association in
Hispanic women with a high incidence of multi-parity
and type 2 diabetes.
In addition pregnancy is associated with significant
weight retention (when the woman is not able to return
to the original pre-pregnancy weight). This can increase
their post pregnancy BMI after each delivery therefore
increasing the risk of type 2 diabetes later in life.
Herein we evaluate the association between parity
(number of live births) and diabetes in a group of post-
menopausal Hispanic women from Colombia. Our main
* Correspondence: pcure@cnmc.org
1Children’s National Health System, 111 Michigan Avenue, NW, Washington
DC 20010, USA
2The George Washington University, Washington DC, USA
Full list of author information is available at the end of the article
METABOLIC SYNDROME
DIABETOLOGY & 
© 2015 Cure et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Cure et al. Diabetology & Metabolic Syndrome  (2015) 7:7 
DOI 10.1186/s13098-015-0001-z
hypothesis was that parity was independently associated
with a higher risk of diabetes in our population.
Methods
This is a cross-sectional study utilizing data collected from
medical histories during Health Community Programs at
Biomelab Research Center in Barranquilla-Colombia. In
this study we tested the association between parity (by
number of live births) with type 2 diabetes in 1,795 post-
menopausal Hispanic women from Colombia. The study
included all post-menopausal women seen at the Health
Community Program that had a complete medical history.
Women with history of diabetes before their first pregnancy
and women with history of hysterectomy were excluded
from this analysis. The total number of patients evaluated
for this analysis was 3,405 of which 1,795 met the inclusion
and exclusion criteria. Data was collected from complete
medical histories of women who attended the Health
Community Programs between 2004–2007 and included:
patient demographics, anthropometric measures (weight
[kg], height [cm], Body Mass Index (BMI) [kg/m2], waist
circumference and hip circumferences [cm]), patient his-
tory of CVD, type 2 diabetes and/or other diseases, parity
history (total number of live births), breastfeeding history
(in months), family history, complete physical exam (in-
cluding systolic/diastolic blood pressures [mmHg] and
heart rate [beats/min]) and smoking history. Women were
divided also according to BMI and WHR risk based on the
World Health Organization criteria.
Logistic regression analyses were performed to deter-
mine whether significant associations between diabetes
and parity existed alone, in a bivariable model, and in a
multivariable model after controlling for: BMI, age, WHR,
smoking history, family history of diabetes and others. For
these analyses the Dependent variable was history of dia-
betes as diagnosed by a doctor and/or based on patient
medical history and/or history of any diabetes treatment.
The main independent variable studied was number of
live births (parity) as a categorical variable divided into the
following 4 groups according to previous publications
[14]: nulliparous (0 deliveries), one or two deliveries (1 or
2), three to five deliveries (3–5) and 6 or more deliveries
(≥6). In addition a bivariable and multivariable analyses
were performed to evaluate the association between family
history of diabetes, WHR, smoking history and breastfeed-
ing. Results are presented in percentages, means and
standard deviation where appropriate.
The study was approved by the local Institutional Review
Board (IRB) in Biomelab, Barranquilla-Colombia and by
the The George Washington University and Medical Cen-
ter, Office of Human Research, IRB board (IRB# 021033).
All patients provided informed consent prior to their
participation in the program and for the future utilization
of the data obtained.
Data analysis was performed using SAS® version 9.1.
Results and discussion
A total of 1,795 postmenopausal Hispanic females were
included in this analysis. Table 1 displays the mean and
standard deviations for continuous variables and frequency
distributions for categorical variables.
The mean number of live births per women in our
population was 4.5 ± 3.0 and the distribution according to
parity groups was 8% nulliparous (n = 139), 19% with 1 or
2 deliveries (n = 342), 42% with 3 to 5 deliveries (n = 758)
and 31% with 6 or more deliveries (n = 556) (Table 1).
Frequency of diabetes was lower in the nulliparous
group when compared to all the other parity groups
(1.4% vs. 6.1%, 7.0% and 10.3%, respectively) (Table 1).
Women with 6 or more deliveries were older and had
higher systolic/diastolic blood pressure compared to the
other groups.
In our study there was a dose-dependent increase in
the diabetes risk in the bivariable analysis, when com-
paring each of the parity groups with the referent group
[0 births] (Table 2). This association was maintained in
the multivariable analysis after adjusting for age, BMI
and family history of diabetes, with the odds of diabetes
being 5.2 (1.2–22.9), 5.5 (1.3–23.0) and 7.5 (1.8–31.8) times
higher, when comparing the referent group with each of
the parity groups, respectively. The association remained
strong for two of the parity groups, except for the 3–5
deliveries after controlling for more variables including:
Age, BMI, Family history of diabetes, WHR, Smoking
history, Breastfeeding and Marital Status (Table 2).
The overall model containing all the variables was
statistically significant (chi2 = 106.9, p < 0.0001), and the
Hosmer-Lemeshow Goodness of Fit test indicated that the
model assumptions were appropriate (Chi2 = 9.2, p = 0.32).
The risk for diabetes according to family history, WHR,
smoking history and breastfeeding was evaluated in a
bivariable and multivariable adjusted analyses (Table 3).
There were strong associations between family history of
diabetes and diabetes risk, odd ratio 4.6 (3.0–7.0) and also
between WHR risk profile and diabetes risk odd ratio 4.1
(2.0–8.1), in both the bivariable and multivariable models.
Conclusions
This is the first study investigating the association be-
tween parity and diabetes risk exclusively in a Hispanic
population. In our study, we found that multiparous
women had a 5–7 fold increased risk of diabetes when
compared to their nulliparous counterparts.
In a recent large, prospective cohort of Singaporean
Chinese women NT Mueller et al. [11] found strong and
graded positive association between parity and type 2
diabetes , after adjusting for various demographic, life-
style, reproductive health factors and BMI.
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The most recent study by Y Tian et al. [12] found that
fasting plasma glucose level and the prevalence of dia-
betes were associated with the number of live births
suggesting that higher parity is a risk factor for diabetes
in their population of Chinese women. This contrasts
with early studies showing slight association between
parity and diabetes that was then lost after controlling
for confounding variables such as age and weight [13].
In addition, prospective studies in other populations
have found an increase in the risk of metabolic syndrome
in multiparous women compared to nulliparous [7,8]
with an 11% increase in the risk of metabolic syndrome
Table 2 Odds ratios for the association between parity and diabetes according to the number of births in a bivariable
and multivariable analyses
Variable No. of subjects affected (%) Odd ratio bivariable analysis Odd ratio adjusted
for multivariables€
Odd ratio adjusted
for multivariables¥
OR (95% confidence intervals)
Diabetes 133 (7.4)
No. of births
0 2 (1.5) 1.0 1.0 1.0
1 or 2 21 (15.8) 4.5 (1.0–19.4) 5.2 (1.2–22.9) 5.0 (1.1–22.9)
3–5 53 (39.8) 5.1 (1.2–21.4) 5.5 (1.3–23.0) 4.1 (0.9–17.9)
≥6 57 (42.9) 7.8 (2.0–32.4) 7.5 (1.8–31.8) 5.3 (1.2–23.5)
€Adjusted for Age, BMI and Family history of diabetes.
¥Adjusted for Age, BMI, Family history of diabetes (Diabetes FHx), WHR, Smoking history, Breastfeeding and Marital Status.
Bolded results = statistically significant p < 0.05.
Table 1 Descriptive statistics (n = 1,795)
Variable All women No. of births
Mean (SD) 0
(n = 139)
1 or 2
(n = 342)
3–5
(n = 758)
≥6
(n = 556)
n Mean (SD)
Age (yr) 1,795 61.9 (10.0) 61.1 (10.3) 57.7 (9.6) 59.8 (9.3) 67.5 (8.7)
Menarque (yr) 1,795 13.4 (1.8) 13.7 (2.0) 13.2 (1.9) 13.3 (1.8) 13.5 (1.7)
Menopause (yr) 1,795 46.9 (5.8) 46.3 (6.0) 46.3 (5.6) 46.6 (5.8) 47.7 (5.9)
BMI (kg/m2) 1,795 26.7 (5.1) 25.6 (5.7) 26.4 (4.6) 27.1 (5.0) 26.7 (5.3)
Waist Circum.(cm) 1,795 86.4 (11.4) 82.9 (12.6) 84.8 (10.9) 86.7 (11.6) 87.9 (11.6)
Hip Circum.(cm) 1,795 101.7(12.2) 98.0 (13.9) 102.0 (11.9) 102.2 (12.1) 101.9 (11.9)
WHR 1,795 0.87 (0.36) 0.90 (0.66) 0.83 (0.08) 0.87 (0.48) 0.87 (0.07)
Systolic BP(mmHg) 1,795 134 (22) 132 (22) 127 (19) 133 (21) 140 (24)
Diastolic BP(mmHg) 1,795 82 (13) 80 (12) 80 (12) 82 (13) 85 (14)
n % n (% row)
BMI category
Underweight 71 4.2 16 (22.5) 9 (12.7) 25 (35.2) 21 (29.6)
Normal 639 37.6 53 (8.3) 132 (20.7) 262 (41) 192 (30.0)
Overweight 626 36.8 38 (6.1) 114 (18.2) 277 (44.2) 197 (31.5)
Obese 364 21.4 25 (6.9) 62 (17.0) 169 (46.4) 108 (29.7)
WHR category
Low risk 366 22.7 37 (10.1) 89 (24.3) 163 (44.5) 77 (21.1)
Moderate risk 453 28.2 44 (9.7) 96 (21.2) 183 (40.4) 130 (28.7)
High risk 791 49.1 49 (6.2) 123 (15.6) 330 (41.7) 289 (36.5)
Disease frequency
Diabetes 133 7.4 2 (1.4) 21 (6.1) 53 (7.0) 57 (10.3)
BMI = Body Mass Index; WHR =Waist Hip Ratio.
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with each delivery [7]. Furthermore, the CARDIA study
showed a direct association between childbearing and
incidence of metabolic syndrome among women with
gestational diabetes mellitus but not among women
without it [8]. Other studies are consistent with our
findings, including Kritz-Silverstein et al. [9] who exam-
ined the relationship between parity and prevalence of
diabetes in a population-based study of 1,186 women
aged 41–92 years, and found that the risk of diabetes
increased slightly with the number of live births independ-
ent of age, BMI and family history of diabetes. Other pro-
spective studies after adjustment for sociodemo-graphic
factors and body fat only observed a greater risk among
gran multiparous women [10].
Our study also found that women in the Higher Risk
category for WHR had 4.3 fold risk of diabetes when
compared to women in the the Low Risk WHR. These
results are in agreement with other studies showing
association between this important anthropometric meas-
ure and diabetes risk [15,16]. Furthermore, we found that
family history of diabetes (FHx) was significantly associ-
ated (OR 4.6) with diabetes.
It is worth noted, that in our population, the prevalence
of type 2 diabetes was 7.4% which is slightly lower of that
reported in other studies, including the Behavioral Risk
Factors Surveillance System (BRFSS), which reported an
age-adjusted self-reported prevalence of diabetes among
Hispanics of 9.8% [17] and a study by Lao et al. that
showed a 9.7% prevalence of diabetes in a large cohort of
Chinese women age 50–93 years old [7]. The lower preva-
lence in our studied population could be explained by
under-diagnosis of diabetes. In an additional analysis of
our data including only 1,098 from our population that
had fasting blood glucose results, we found that the
prevalence of diabetes by history in this population was
8.7% and, in the same population, the prevalence of dia-
betes by fasting blood glucose results was 11.9%, suggest-
ing that the percentage of undiagnosed diabetes in our
population was about 3.2%, similar to the 3% prevalence
of undiagnosed diabetes reported by Cowie et al. for
Mexican-Americans [18].
The fact that populations in Latin American countries
are showing a higher tendency towards developing meta-
bolic diseases (ie. type 2 diabetes) and cardiovascular
disease has been recognized [18,19]. Furthermore, the
US National Health and Nutrition Examination Survey
(NHANES) showed higher rates of overweight and obesity
in minority groups when compared to non-Hispanic
whites [20]. These higher risk for metabolic disorders
coupled with a “high” parity rate may both be contributing
factors for the markedly increased risk of type 2 diabetes
observed in our population.
Prospective studies, especially in populations with
similar characteristics, should be carried-out in order to
more accurately answer our hypothesis. Still our results
can be an early and reliable source of information that
could help designing disease prevention programs while
gaining 10 years in the process and while we wait for the
results of prospective studies [21].
One of the recommendations, based on this study, is
to suggest additional laboratory work-up as part of the
routine check-up that may include fasting glucose and
an oral glucose tolerance test (when recommended) in
postmenopausal multiparous and gran multiparous women,
especially those of Hispanic origin. Early prevention pro-
grams in postmenopausal women need to include family
history of diabetes, increased WHR and multi-parity as
important risk factors for diabetes in this population. In
addition, well designed programs to prevent excessive
weight gain during each delivery may help diminish the
health impact of parity, later on in life.
The implications of our results in other Hispanic popu-
lations, including Hispanics living in developed countries,
such as in the United States, are unknown. Environmental
factors, such as high-caloric foods, lack of exercise and
other lifestyle factors differ between Hispanics living in
their countries of origin and Hispanics in the US. These
differences make the results in our populations difficult
to extrapolate to the US Hispanic population, but our
recommendations of including multiparity in the risk
profile for postmenopausal women and developing pre-
vention programs tailored to this population may also
be applicable to Hispanic women in the US.
As any cross-sectional study, our study has several
limitations. One of them is the lack of information about
the onset of diabetes according to the time of each birth
which could be a factor for patients that developed the
disease before their last birth which may overestimate
Table 3 Relative risk of diabetes according to family Hx,
WHR, smoking and breastfeeding in a bivariable and
multivariable analyses
Variable Odd ratio
bivariable analysis
Odd ratio adjusted
for multivariables¥
95% confidence intervals
Diabetes
Family Hx of diabetes 3.8 (2.6–5.4) 4.6 (3.0–7.0)
Yes (ref) vs. no
WHR high (ref) vs. low 4.3 (2.3–8.1) 4.1 (2.0–8.1)
WHR moderate (ref) vs. low 1.5 (0.7–3.2) 1.6 (0.7–3.5)
Ever smoking 1.0 (0.7–1.6) 1.2 (0.7–1.9)
Yes (ref) vs. no 1.1 (0.8–1.6) 0.9 (0.6–1.4)
Breastfeeding (months)
6 or more (ref) vs. 0–6
¥Adjusted for Age, BMI, Family history of diabetes (Diabetes FHx), WHR
risk, Smoking history, Breastfeeding history and Marital Status Bolded
results = statistically significant p < 0.05.
Ref = Referent Group.
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the association between diabetes and parity in the higher
parity groups. Another limitation is the lack of informa-
tion about gestational diabetes or the history of macro-
somia in any of the newborns. Finally, weight gain after
each delivery was not recorded and this could be an
important factor in the development of diabetes in these
populations.
In conclusion, in our study we found a strong associ-
ation between parity and diabetes in postmenopausal
Hispanic women as well as an association between
positive family history of diabetes and high WHR with
diabetes in the same population.
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